Sharon Benzeno, Chief Business Development Officer at Adaptive Biotechnologies Corp (ADPT), sold 13,540 shares at $48.20 ($662K) on 2020-12-01, disclosed to the SEC on 2020-12-02.
Open-market sale of $662k ADPT by Chief Business Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.20 | 3,077 | $148K | 22.4% |
| 2 | $48.20 | 3,077 | $148K | 22.4% |
| 3 | $49.43 | 3,693 | $183K | 27.6% |
| 4 | $49.43 | 3,693 | $183K | 27.6% |
| Total | $48.87 avg | 13,540 | $662K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |